The early infantile onset ‘‘congenital’’ variant of Rett syndrome presents with deviations of behavior from very early infancy. Here, we report on a clinical-genetic study in a collected series of 14 Swedish girls with early infantile onset Rett syndrome phenotype. The clinical diagnosis was based on symptom onset before the age of 6 months and the patients fulfilled 3 or more Rett variant criteria and 5 or more supportive criteria. Genotype-phenotype correlation studies in the CDKL5-gene have recently shown clinical associations to early infantile onset Rett variants. Mutation analyses for both the MECP2-gene and the CDKL5-gene were, therefore, performed. Of interest, we found a large deletion covering 2 exons in MECP2, which underlines the importance of MECP2 mutation screening even for the ‘‘atypical’’ early infantile onset variants of Rett syndrome. No early infantile onset Rett syndrome patients in this study had the previously well-known hotspot mutations in the MECP2-gene.
Hagberg BA, Skjeldal OHRett variants: a suggested model for inclusion criteria. Pediatr Neurol. 1994;11:5-11.
2.
Amir RE, Van den Veyver IB, Wan M., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methylCpG-binding protein 2. Nat Genet. 1999 ;23:185-188.
3.
Weaving LS, Christodoulou J., Williamson SL, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet . 2004;75: 1079-1093.
4.
Scala E., Ariani F., Mari F., et al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet. 2005;42: 103-107.
5.
Mari F., Azimonti S., Bertani I., et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet. 2005;14: 1935-1946.
6.
Hagberg B.Rett syndrome: the diagnostic criteria and the clinical variants. Rev Neurol Separata. 2004;38:26-28.
7.
Williams CA, Beaudet AL, Clayton-Smith J., et al. Angelman syndrome 2005: updated consensus for diagnostic criteria . Am J Med Genet. 2006;140:413-418.
8.
Erlandson A. , Samuelsson L., Hagberg B., et al. Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients. Genet Test. 2003;7:329-332.
9.
Kubota T., Das S., Christian SL, et al. Methylation-specific PCR simplifies imprinting analysis. Nat Genet. 1997;16:16-17.
10.
Wahlstrom J. , Uller A., Johannesson T., et al. Congenital variant Rett syndrome in a girl with terminal deletion of chromosome 3p. J Med Genet . 1999;36:343-345.
11.
Malmgren H. , Sahlen S., Wide K., et al. Distal 3p deletion syndrome: detailed molecular cytogenetic and clinical characterization of three small distal deletions and review. Am J Med Genet. 2007 ; 143:2143-2149.
12.
Couvert P., Bienvenu T., Aquaviva C., et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001;10:941-946.
13.
Hagberg B., Hanefeld F., Percy A., et al. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting , Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol. 2002;6:293-297.
14.
Hagberg B., Goutieres F., Hanefeld F., et al. Rett syndrome: criteria for inclusion and exclusion. Brain Dev. 1985;7:372-373.
15.
Hagberg B., Erlandsson A., Kyllerman M., et al. Odd MECP2-mutated Rett variant-long-term follow-up profile to age 25. Eur J Paediatr Neurol. 2003;7:417-421.
16.
Erlandson A. , Hagberg B.MECP2 abnormality phenotypes: clinicopathologic area with broad variability. J Child Neurol. 2005; 20:727-732.
17.
Cope DW, Di Giovanni G., Fyson SJ, et al. Enhanced tonic GABAA inhibition in typical absence epilepsy . Nat Med. 2009; 15:1392-1398.
18.
Palma E., Roseti C., Maiolino F., et al. GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) ‘‘phasic’’ receptors . Proc Natl Acad Sci U S A. 2007;104:20944-20948.
19.
Komatsu M., Wang QJ, Holstein GR, et al. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci U S A. 2007;104:14489-14494.
20.
Komatsu M., Waguri S., Chiba T., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880-884.
21.
Archer HL, Evans J., Edwards S., et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet . 2006;43: 729-734.
22.
Wagenstaller J., Spranger S., Lorenz-Depiereux B., et al. Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet. 2007 ;81:768-779.
23.
Froyen G., Van Esch H., Bauters M., et al. Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes. Hum Mutat. 2007 ;28:1034-1042.
